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Maternal one-carbon (1-C) metabolism provides methylgroups for fetal development and programing by DNA methylation as one of the
underlying epigenetic mechanisms. We aimed to investigate maternal 1-C biomarkers, folic acid supplement use, and MTHFR C677T
genotype as determinants of 1-C metabolism in early pregnancy in association with newborn DNAmethylation levels of fetal growth and
neurodevelopment candidate genes. The participants were 463 mother–child pairs of Dutch national origin from a large population-
based birth cohort in Rotterdam, The Netherlands. In early pregnancy (median 13.0 weeks, 90% range 10.4–17.1), we assessed the
maternal folate and homocysteine blood concentrations, folic acid supplement use, and the MTHFR C677T genotype in mothers and
newborns. In newborns, DNA methylation was measured in umbilical cord blood white blood cells at 11 regions of the seven genes:
NR3C1, DRD4, 5-HTT, IGF2DMR, H19, KCNQ1OT1, andMTHFR. The associations between the 1-C determinants and DNAmethylation
were examined using linear mixed models. An association was observed between maternal folate deficiency and lower newborn
DNA methylation, which attenuated after adjustment for potential confounders. The maternal MTHFR TT genotype was significantly
associated with lower DNA methylation. However, maternal homocysteine and folate concentrations, folic acid supplement use, and
the MTHFR genotype in the newborn were not associated with newborn DNA methylation. The maternal MTHFR C677T genotype,
as a determinant of folate status and 1-C metabolism, is associated with variations in the epigenome of a selection of genes in
newborns. Research on the implications of these variations in methylation on gene expression and health is recommended.
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Epigenetics has gained interest as it is proposed to be an
interface between the dynamic environment and the
genome. DNA methylation, one of the best known
epigenetic mechanisms, is essential for embryogenesis,
fetal programing, and development (Waterland & Jirtle
2004, Shames et al. 2007).
One-carbon (1-C) metabolism plays a crucial role in
DNA methylation as it determines the flux of
methylgroups toward synthesis or methylation of DNA.
Folate and choline are the main sources of methyl groups
in 1-C metabolism that enables the conversion ofq 2014 Society for Reproduction and Fertility
ISSN 1470–1626 (paper) 1741–7899 (online)homocysteine into methionine, which in turn leads to
the production of S-adenosylmethionine (SAM) as a
principal methyldonor for DNA methylation (Crider et al.
2012). The 1-C metabolism is influenced by common
polymorphisms, in particular the methylene tetrahydro-
folate-reductase (MTHFR) C677T polymorphism, which
interacts with the folate status and DNA methylation,
in particular in situations of folate deficiency (Crider
et al. 2011). In addition to genetic variants, dietary folate
intake, folic acid supplement use, lifestyle, and medi-
cation are known to influence the folate status
(Steegers-Theunissen et al. 2013). Our group previously
reported higher levels of insulin-like growth factor 2DOI: 10.1530/REP-14-0260
Online version via www.reproduction-online.org
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very young children after periconceptional exposure to
maternal folic acid supplement use (Steegers-Theunissen
et al. 2009). This is supported by human and animal
studies also emphasizing the importance of the 1-C
pathway in fetal programing (Gueant et al. 2013,
Steegers-Theunissen et al. 2013).
A low maternal folate status during pregnancy has
been associated with an increased risk of pregnancy
complications, intrauterine growth restriction, and
developmental disorders including learning disabilities
and emotional problems (Bergen et al. 2012, Fekete et al.
2012, Kim et al. 2012, van Uitert et al. 2013). In
addition, polymorphisms in the MTHFR gene are
suggested to contribute to the risk of developing
psychiatric disorders, including depression, schizo-
phrenia, and bipolar disorder (Gilbody et al. 2007).
It can be concluded that alterations in the availability
of folate during pregnancy may lead to variations in
DNA methylation patterns in the offspring, which
sometimes also change gene expression and outcomes
of disease (Niculescu & Zeisel 2002, Waterland et al.
2006, Sinclair et al. 2007). Against this background,
we investigated the determinants of maternal 1-C
metabolism in early pregnancy, i.e. folate and
homocysteine concentrations, polymorphisms of the
folate metabolizing gene MTHFR C677T (rs1801133),
and folic acid supplement use in association with the
newborn epigenome.
We related these factors to the overall DNA methyl-
ation status of seven genes that were selected based
on literature. Variations in these genes are assumed
to influence neuronal development (glucocorticoid
receptor (NR3C1), presynaptic genes (dopamine receptor
D4 (DRD4) and serotonin transporter protein (5-HTT)) or
fetal growth (IGF2DMR, H19, and potassium channel
protein (KCNQ1OT1)), and 1-C metabolism, i.e.MTHFR.Materials and methods
Design and study population
This study was embedded in the Generation R Study, an
ongoing population-based birth cohort followed from fetal life
onwards in Rotterdam, The Netherlands. The Generation R
Study, designed to identify early environmental and genetic
determinants of growth, development and health, has been
previously described in detail (Jaddoe et al. 2012).
The study population comprised a subset (nZ540) of
mother–child pairs of the original Generation R cohort. To
reduce the effect of population stratification, we first restricted
the study population to the newborns of Dutch national origin
based on the country of birth of the parents and grandparents.
Next, we selected newborns with a sufficient quantity and
quality of DNA derived from umbilical cord blood white blood
cells. Finally, we oversampled newborns diagnosed with
attention-deficit hyperactive disorder (ADHD; nZ92) in child-
hood and those born small for gestational age (SGA, nZ100),Reproduction (2014) 148 581–592because of previous study questions (Bouwland-Both et al.
2013, van Mil et al. 2014), and 348 newborns were randomly
selected from the original cohort. We carried out the analyses
with and without the oversampled ADHD and SGA newborns.
The current study assessed multiple determinants of the 1-C
metabolism (i.e. maternal and cord blood folate and homo-
cysteine concentrations, maternal folic acid supplement use, and
maternal and newbornMTHFRC677T genotype) in relation to the
outcome. To avoid the loss of power and bias due to complete
case selection, we performed the analyses in samples of varying
size: of the 540 mother–child pairs 413 (76%) had data on
maternal early pregnancy (median 13.0 weeks of gestation, 90%
range 10.4–17.1) plasma folate, and homocysteine concen-
trations. Plasma folate and homocysteine concentrations of the
newborn were measured in 420 (77%) mother–child pairs.
Information on maternal folic acid supplement use was
present for 440 (81%) of the 540 mother–child pairs. Maternal
MTHFR C677T genotype was available in 463 (86%) mother–
child pairs and information about the newborn MTHFR C677T
genotype in 473 mother–child pairs (88%). The study has been
approved by the Medical Ethics Committee of the Erasmus MC,
University Medical Centre, Rotterdam, The Netherlands.
Assessment of biomarkers of 1-C metabolism
In early pregnancy (median gestational age 13.0 weeks, 90%
range 10.4–17.1), venous blood samples were drawn in plain
tubes for the determination of plasma folate and homocysteine.
The samples were transported to the regional laboratory for
storage at K80 8C within 3 h after sampling. Ethylenediami-
netetraacetic acid plasma samples were picked and analyzed
using an immunoelectrochemoluminescence assay on the
Architect System (Abbott Diagnostics B.V.). The between-run
coefficients of variation (CV) for plasma folate were 8.9% at
5.6 nmol/l, 2.5% at 16.6 nmol/l, and 1.5% at 33.6 nmol/l, with
an analytical range of 1.8–45.3 nmol/l. The same CV for
plasma homocysteine were 3.1% at 7.2 mmol/l, 3.1% at
12.9 mmol/l, and 2.1% at 26.1 mmol/l, with an analytic range
of 1–50 mmol/l (Bergen et al. 2012).
Maternal folic acid supplement use
In early pregnancy, at the same moment of blood sampling,
self-administered questionnaires were filled in by the mothers
to obtain information on the use and initiation of folic acid
and multivitamin supplements. In The Netherlands, a daily
supplement of 0.4–0.5 mg folic acid is advised to the general
population of women planning pregnancy up to 10 weeks
of gestation (Weggemans et al. 2009). The mothers were
categorized according to the moment of initiation of
periconception folic acid supplement use as follows:
i) preconception initiation, ii) initiation after conception but
before 10 weeks of gestation, or iii) no use. This categorization
has been applied to previous publications from the same
study cohort (Roza et al. 2010).MTHFR genotyping
To assess the genotypes, DNA was extracted from white blood
cells obtained from mothers in early pregnancy and newbornswww.reproduction-online.org
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(rs1801133) was performed by using TaqMan allelic discrimi-
nation assay (Applied Biosystems, Foster City, CA) and Abgene
QPCR ROX mix (Abgene, Hamburg, Germany). The genotyping
reaction was amplified by using the GeneAmp PCR system 9700
(95 8C for 15 min), then 40 cycles of 94 8C (15 s) and 60 8C
(1 min). The fluorescence was detected on the 7900HT Fast
Real-Time PCR System (Applied Biosystems), and individual
genotypes were determined by using SDS Software (version 2.3;
Applied Biosystems). The frequency distributions agreed with
the Hardy–Weinberg equilibrium (Supplementary Table 2, see
section on supplementary data given at the end of this article).Measurements of DNA methylation
Based on literature, we selected genes implicated in fetal
growth and neuronal development 5-HTT, DRD4, IGF2DMR,
H19, KCNQ1OT1, NR3C1, CCNL1/LEKR1 and 1-C metab-
olism, i.e. MTHFR (Supplementary Table 1, see section on
supplementary data given at the end of this article). Hence, we
chose to investigate the CpG islands of the genes. We selected
the middle region or outer regions per CpG island or the region
previously investigated by other groups.
Two regions of the 5-HTT gene were selected based on
publication by Philibert et al. (2008), in which the relationship
with depression and alcohol dependency has been
investigated.
Previously, Wong et al. (2010) described epigenetic
differences in twins in the region of the DRD4 gene and one
of the regions in the 5-HTT gene. Epigenetic regulation of the
NR3C1 gene has been associated with childhood abuse
(McGowan et al. 2009). We selected the same regions of the
IGF2DMR and H19 gene as previously reported by Talens et al.
(2010), which are implicated in fetal growth. The primers of the
other regions in the KCNQ1OT1, MTHFR, and NR3C1 genes
were designed using the online tool of EpiDesigner (www.
epidesigner.com).
The isolated genomic DNA (500 ng) from cord blood
samples was treated with sodium bisulfite for 16 h using the
EZ-96 DNA Methylation Kit (Shallow; Zymo Research, Irvine,
CA, USA). This was followed by PCR amplification, fragmenta-
tion after RT, and analysis on a mass spectrometer (Sequenom,
Inc., San Diego, CA, USA). This generated mass spectra that
were translated into quantitative DNA methylation levels of
different CpG sites by MassARRAY EpiTYPER Analyzer
Software (v1.0, build 1.0.6.88; Sequenom, Inc.).
The samples were randomly divided over bisulfite conver-
sion batches. For each individual, the assays were amplified
from the same bisulfite-treated DNA. All methylation measure-
ments were performed in triplicate from the same bisulfite-
treated DNA. Fragments containing one or more CpG sites
were called CpG units. The following procedure has been
followed for the quality control of the methylation data:
i) exclusion of CpG units with too low or too high mass or CpG
units with overlapping or duplicate RNA fragments (e.g. silent
signals), ii) for inclusion of CpG units at least two out of three
replicate measurements per CpG unit had to be successful,
iii) for inclusion of CpG units the S.D. of the triplicates (or
duplicates) had to be%0.10 and the success rate per CpG unitwww.reproduction-online.orghad to be R75%, and iv) exclusion of CpG units with the
interference of single-nucleotide polymorphisms (CEU) (SNPs)
with a frequency O5% as this could interfere with the
measurement by a change of weight of the CpG unit. Because
the assessment of the selected region near the gene
CCNL1/LEKR1 was unsuccessful due to measurement errors,
this data were not analyzed any further.Covariates
The following possible confounders were based on expertise
and literature review (Steegers-Theunissen et al. 2009,
Obermann-Borst et al. 2011, McKay et al. 2012).
Information on maternal education, prenatal smoking, and
alcohol consumption was obtained by questionnaires during
early pregnancy. The educational level of the mother was
assessed by the highest completed education and reclassified
into three categories: primary school only, secondary school,
and higher education. Maternal prenatal was classified as
‘non-smoking’, ‘smoking until pregnancy was confirmed’, and
‘continued smoking during pregnancy’. Data on newborn
gender, birth weight, and gestational age at birth were derived
from medical records completed by midwives and gynecolo-
gists. Birth weight was expressed as gestational age and gender-
adjusted SDSs (Verburg et al. 2008).Statistical analysis
First, we examined the association between a derangement in
maternal 1-C metabolism, reflected by a low plasma folate or
high homocysteine, and newborn DNA methylation of all
genes combined. Therefore, we tested for a threshold effect of
folate deficiency defined as a plasma concentration of
!7 nmol/l (percentile 6.4; Simpson et al. 2010). In a similar
way, we tested for associations between maternal plasma
homocysteine concentration of O11 mmol/l (percentile 95.2)
and child DNA methylation levels (Hague 2003).
Next, we used plasma folate and homocysteine as a
continuous variable in the equation. To understand the effect
of potential confounders on DNA methylation we used a crude
and an adjusted model with gestational age at the moment of
blood sampling, maternal smoking, and gestational age at birth
as covariates. The covariates were selected and included in the
models if they changed the effect estimates of the main
association (maternal folate concentration and newborn DNA
methylation level)O10% (Walter & Tiemeier 2009). Maternal
alcohol consumption was not included in models because this
did not materially change the effect estimates.
In addition, we tested for an association between folic acid
supplement use and newborn DNA methylation, with mothers
who initiated the use of folic acid supplements preconception-
ally as the reference category.
Finally, we used the maternal MTHFR rs1801133 genotype
as a proxy for baseline folate status to study the association
between folate status and child DNA methylation. Based on
studies investigating folate and homocysteine concentrations in
individuals heterozygous and homozygous for the 677T allele
(Frosst et al. 1995, Jacques et al. 2002), we used a recessive
model using both the CC and CT genotypes as reference withReproduction (2014) 148 581–592
Table 1 Characteristics of the mothers and their newborns.
nZ420
Newborn
Gender, boys (%) 60.2
Birth weight (g) 3404 (582)
Mother
Age (years) 30.1 (4.8)
Parity, nulliparous (%) 66.3
Gestational age at study entry (weeks),
median (90% range)
13.0 (10.4–17.1)
Gestational age at delivery (weeks) 40.1 (1.5)
BMI (kg/m2) 24.1 (4.0)
Educational level (%)
Primary 19.8
Secondary 50.7
High 29.5
Smoking during pregnancy (%)
Never 67.1
Until pregnancy confirmation 9.8
Continued 23.1
Periconceptional folic acid supplement use (%)
Start preconceptionally 55.9
Start within first 10 weeks of gestation 31.4
No use 12.7
Plasma folate concentrations in early
pregnancy (nmol/l)
19.1 (9.0)
Plasma homocysteine concentrations in
early pregnancy (mmol/l), median
(90% range)
7.0 (4.9–10.9)
Mode of delivery (%)
Spontaneous vaginal 71.8
Instrumental vaginal 21.7
Caesarean section 6.5
Values represent means (S.D.) unless otherwise indicated.
584 N H van Mil and othersthe TT alleles as risk genotype. To check whether the genetic
effects were specific for the mother, we additionally tested for
an association between child MTHFR genotype and DNA
methylation.
As SNPs have previously been found to be correlated with
local DNA methylation patterns, mostly within a distance of
149 kb of CpG dinucleotides (Zhang et al. 2010, Bell et al.
2011), we also tested the associations after excluding the
MTHFR region in the analysis. In addition, to test whether
results were dependent on the sampling strategy with an
oversampling of newborns with childhood ADHD or those
born SGA, all analyses were repeated excluding these samples.
For an initial overall analysis of methylation and ADHD
symptom score, DNA methylation levels of all CpG units in the
11 regions together were combined in one analysis. We present
the complete data from all regions selected and chose a
hierarchical approach to reduce the risk of type 1 error rather
than to report selectively. Next to specific effects of DNA
methylation, general effects on the level of DNA methylation
have been described. Besides, the specific regions are
correlated; a combined analysis increases the power and
helps to detect small effects of DNA methylation. Conse-
quently, we have to be very careful to interpret specific effects
on DNA methylation as the focus was on the overall effect.
DNA methylation levels were treated as continuous
variables. To approximate normal distribution, variables of
DNA methylation levels were transformed by the square-root.
In the analyses, the triplicate measurements and DNA
methylation levels of the separate CpG sites within a region
were treated as clustered variables in a restructured data file
and not as a mean.
As CpG sites within one region might be correlated, the
associations with DNA methylation level were calculated using
linear mixed models. Mixed models have the advantage to
allow correlated random effects in individuals. Another
advantage of this model is the ability to accommodate missing
data points. Furthermore, using mixed models enables
adjustment for relevant covariates on the raw data in the
same model (Burton et al. 1998).
To further illustrate the effect of maternal MTHFR C677T
genotype, we tested the association between the different
maternal alleles and newborn cord blood concentrations of
folate and homocysteine using ANOVA. In addition, we tested
the association between maternal periconceptional folic acid
supplement use and maternal early pregnancy plasma folate
and homocysteine concentrations.
Finally, to test whether our sampling strategy influenced our
results, we carried out the analyses with and without the
oversampled ADHD and SGA newborns. All analyses were
performed using SPSS Software (version 20.0; IBM–SPSS).Results
The characteristics of the newborns and their mothers in
the study population are presented in Table 1. Mothers
had a mean age of 30.1 years (S.D. 4.8), 29.5% was
higher educated and 32.9% smoked during pregnancy.
The children were born after a mean of 40.1 weeks of
gestation (S.D. 1.5), 71.8% was born after spontaneousReproduction (2014) 148 581–592vaginal delivery and the mean birth weight was 3404 g
(S.D. 582).
The associations between maternal folate and homo-
cysteine concentrations in early pregnancy and overall
DNA methylation levels in the 11 regions of seven fetal
growth and neuronal developmental genes in the
newborn are shown in respectively Tables 2 and 3. The
continuous analysis of the maternal biomarkers showed
no significant associations with the DNA methylation
levels in newborns. However, early pregnancy exposure
to folate deficiency, resulting in a deranged 1-C
metabolism, revealed an overall lower DNA methylation
level (b K0.39, 95% CI K0.74; K0.03, PZ0.03)
that was attenuated after adjustment for potential
confounders. The homocysteine concentration was not
associated with newborn DNA methylation levels in the
overall analyses of all regions measured.
Newborns of mothers who initiated folic acid
supplement use in the first 10 weeks of gestation or did
not use folic acid supplements did not show different
DNA methylation levels compared with newborns of
mothers who initiated folic acid supplement use
preconceptionally, the reference category (Table 4).
As presented in Table 5, the maternal MTHFR risk
genotype (TT) predicted a lower overall DNA methyl-
ation level in the newborn (b K0.31, 95% CI K0.59;
K0.02, PZ0.03). As SNPs can influence DNAwww.reproduction-online.org
Table 2 Associations between maternal early pregnancy plasma folate and newborn DNA methylation levels.
Methylation b (95% CI)
Unadjusted Adjusted
Continuous (mmol/l)
Deficient!7 nmol/l
(nZ27) Continuous (mmol/l)
Deficient!7 nmol/l
(nZ27)
Overall
All genes assessed K3.98 (K13.75; 5.80) K0.39 (K0.74; K0.03) K9.08 (K20.0; 1.85) K0.01 (K0.40; 0.38)
P value 0.42 0.03 0.10 0.95
Neurotransmitter systems
DRD4 K8.81 (K60.27; 42.67) K1.71 (K3.57; 0.15) K51.59 (K105.37; 2.20) K0.07 (K1.99; 1.86)
P value 0.74 0.07 0.06 0.94
5-HTT_a 7.56 (K6.87; 21.99) K0.11 (K0.64; 0.41) 7.99 (K7.76; 23.75) K0.17 (K0.73; 0.39)
P value 0.30 0.67 0.32 0.54
5-HTT_b K6.66 (K23.08; 9.76) K0.23 (K0.85; 0.38) K14.73 (K31.37; 2.42) 0.12 (K0.51; 0.74)
P value 0.43 0.46 0.09 0.72
5-HTT_c K13.04 (K30.00; 3.90) 0.03 (K0.05; 0.10) K17.82 (K35.85; 0.20) K0.05 (K0.68; 0.59)
P value 0.13 0.59 0.05 0.89
Metabolism
NR3C1_a 7.33 (K1.72; 16.37) K0.51 (K0.84; K0.19) 8.69 (K1.22; 18.60) K0.60 (K0.94;K0.25)
P value 0.11 0.002 0.09 0.001
NR3C1_b 4.74 (K6.84; 16.32) K0.36 (K0.77; 0.06) 3.53 (K9.10; 16.16) K0.21 (K0.65; 0.24)
P value 0.42 0.09 0.58 0.37
NR3C1_c 2.73 (K7.95; 13.41) K0.05 (K0.43; 0.34) 3.69 (K7.95; 15.34) K0.03 (K0.44; 0.38)
P value 0.62 0.81 0.53 0.89
MTHFR5 K1.35 (K9.84; 7.14) 0.02 (K0.29; 0.32) K4.07 (K13.23; 5.09) 0.09 (K0.24; 0.42)
P value 0.76 0.91 0.38 0.59
Fetal growth
H19 K18.32 (K44.38; 7.74) K23.08 (K1.18; 7.17) 15.70 (K44.25; 12.84) K0.27 (K1.29; 7.47)
P value 0.17 0.63 0.28 0.60
IGF2DMR 7.72 (K28.15; 43.59) K1.08 (K2.39; 0.24) 3.32 (K35.32; 41.95) K0.74 (K2.13; 0.65)
P value 0.67 0.11 0.87 0.30
KCNQ1OT1 K23.74 (K53.56; 6.07) K0.24 (K1.33; 0.85) K21.90 (K54.45; 10.65) K0.41 (K1.58; 0.75)
P value 0.12 0.66 0.19 0.48
The b represents the change in methylation %/1 mmol per l increase in folate concentration (continuous) or the change in methylation % in folate
deficiency (!7mmol/l) compared with adequate concentrationsR7 mmol/l as analyzed with linear mixed models. Values represent b, 95% CIs, and
P values. Analyses are adjusted for gestational age at the moment of blood sampling, maternal educational level, smoking, child gender, birth weight,
and gestational age at birth. The bold values indicate statistical significance at the aZ0.05 level.
Pregnancy one-carbon metabolism and DNA methylation 585methylation in the adjacent region, we checked whether
this association was dependent on methylation levels in
the measured MTHFR region. The association between
the maternal MTHFR C677T genotype and DNA
methylation level in the newborn was also observed
after excluding the MTHFR region from the analyses
(b K0.37, 95% CI K0.68;K0.04, PZ0.02). There was
no significant association between the newborn MTHFR
C677T genotype and overall DNA methylation.
We were not able to investigate whether the effect of
the folate concentration was modified by the maternal
MTHFR C677T genotype due to the small number of
newborns (nZ4) exposed to folate deficiency in mothers
carrying the MTHFR TT genotype.
Maternal MTHFR C677T genotype was not associated
with alterations in newborns’ cord blood folate or
homocysteine levels (Supplementary Table 3, see section
on supplementary data given at the end of this article).
The plasma folate concentrations measured in early
pregnancy were highest in women starting folic acid
supplement use preconceptionally (mean 21.92 nmol/l,
95% CI 20.76; 23.01) compared with women starting
folic acid supplement use in the first 10 weeks ofwww.reproduction-online.orggestation (18.33 nmol/l, 95% CI 16.81; 19.86, P%0.001)
or women not using folic acid supplements (mean
8.59 nmol/l, 95% CI 6.24; 10.93, P!0.001). Early
pregnancy homocysteine concentrations were lower in
women using folic acid supplements preconceptionally
(mean 7.11 mmol/l, 95% CI 6.80; 7.43) as compared
with women starting folic acid supplements in the first 10
weeks of gestation (mean 7.46 mmol/l, 95% CI 7.05;
7.88, PZ0.19) or women not using folic acid supple-
ments (mean 9.37 mmol/l, 90% range 8.87; 10.02,
P!0.001) (Supplementary Table 4, see section on
supplementary data given at the end of this article).
When analyses were repeated with exclusion of
newborns SGA or with ADHD, the results did not
change materially (results not shown).Discussion
Main findings
There is a substantial interest in the impact of
derangements in periconception maternal 1-C metab-
olism on newborn DNA methylation profiles with
implications for birth outcome and healthReproduction (2014) 148 581–592
Table 3 Associations between maternal pregnancy plasma homocysteine and newborn DNA methylation levels.
Methylation b (95% CI)
Unadjusted Adjusted
Continuous (mmol/l)
Elevated homocysteine
O11 mmol/l (nZ30) Continuous (mmol/l)
Elevated homocysteine
O11 mmol/l (nZ30)
Overall
All genes assessed K0.01 (K0.05; 0.02) K0.05 (K0.39; 0.29) 0.00 (K0.03; 0.04) 0.06 (K0.27; 0.39)
P value 0.48 0.76 0.87 0.73
Neurotransmitter systems
DRD4 K0.06 (K0.26; 0.14) K0.45 (K2.22; 1.33) 0.03 (K0.17; 0.23) 0.26 (K1.51; 2.03)
P value 0.53 0.62 0.74 0.77
5-HTT_a 0.03 (K0.03; 0.09) K0.03 (K0.52; 0.47) 0.02 (K0.04; 0.08) K0.04 (K0.55; 0.47)
P value 0.29 0.91 0.46 0.87
5-HTT_b 0.00 (K0.06; 0.07) K0.10 (K0.67; 0.47) 0.03 (K0.04; 0.09) 0.09 (K0.47; 0.64)
P value 0.89 0.73 0.40 0.76
5-HTT_c K0.05 (K0.11; 0.02) K0.37 (K0.96; 0.23) K0.04 (K0.11; 0.03) K0.28 (K0.88; 0.31)
P value 0.16 0.23 0.24 0.35
Metabolism
NR3C1_a K0.04 (K0.08;K0.01) K0.27 (K0.58; 0.04) K0.04 (K0.08; K0.04) K0.26 (K0.58; 0.06)
P value 0.02 0.09 0.03 0.11
NR3C1_b K0.04 (K0.08; 0.01) K0.38 (K0.78; 0.02) K0.03 (K0.08; 0.02) K0.39 (K0.80; 0.02)
P value 0.11 0.06 0.20 0.07
NR3C1_c K0.02 (K0.06; 0.02) K0.29 (K0.66; 0.09) K0.02 (K0.06; 0.03) K0.33 (K0.71; 0.06)
P value 0.40 0.13 0.45 0.10
MTHFR5 K0.03 (K0.07; 0.00) K0.16 (K0.46; 0.13) K0.03 (K0.07; 0.00) K0.11 (K0.41; 0.19)
P value 0.04 0.27 0.07 0.48
Fetal growth
H19 0.09 (K0.01; 0.19) 1.00 (0.10; 1.90) 0.09 (K0.01; 0.20) 0.92 (K0.01; 1.86)
P value 0.07 0.03 0.09 0.05
IGF2DMR K0.06 (K0.21; 0.08) K0.29 (K1.55; 0.96) K0.08 (K0.23; 0.07) K0.32 (K1.60; 0.96)
P value 0.41 0.65 0.30 0.62
KCNQ1OT1 0.06 (K0.06; 0.18) 0.10 (K0.95; 1.15) 0.05 (K0.07; 0.18) 0.05 (K1.03; 1.14)
P value 0.33 0.85 0.40 0.92
The b represents the change in methylation %/1 mmol per l increase in homocysteine concentration (continuous) or the change in methylation % in
elevated homocysteine concentration (O11 mmol/l) compared with adequate concentrations %11 mmol/l as analyzed with linear mixed models.
Values represent b, 95% CIs, and P values. Analyses are adjusted for gestational age at the moment of blood sampling, maternal educational level,
smoking, child gender, birth weight, and gestational age at birth. The bold values indicate statistical significance at the aZ0.05 level.
586 N H van Mil and others(Steegers-Theunissen et al. 2013). In this study, we
observed a significant association between the maternal
MTHFR 677TT genotype and newborn overall DNA
methylation levels of fetal growth and neuronal develop-
mental genes. The association between maternal folate
deficiency measured in early pregnancy and newborn
DNA methylation was attenuated after correction for
maternal educational level, smoking, child gender, birth
weight, and gestational age at birth.Strengths and limitations
Some strengths and limitations have to be addressed.
This study was embedded in a large cohort, from which a
selection of Dutch newborns was studied. Detailed
information on maternal folate and homocysteine
concentrations, folic acid supplement use, and MTHFR
C677T genotype in mothers and newborns was pro-
spectively collected. Furthermore, to correct for possible
confounding factors, including information on maternal
educational level, smoking and child birth weight have
been carefully documented.
A first limitation is the unsolved question how
alterations in DNA methylation profiles in umbilicalReproduction (2014) 148 581–592cord blood white blood cells reflect DNA methylation
profiles in other tissues. This is a problem in most human
studies. Ghosh et al. (2010) analyzed DNA methylation
variation across brain and blood and found that,
although between-tissue variation exceeds between-
individual variation, inter-individual variation was
reflected across brain and blood. This implies that
peripheral tissues may be of use for epidemiological
studies. Talens et al. (2010) reported for four of eight
investigated regions, including IGF2DMR and H19 used
in the current study, strong correlations between DNA
methylation profiles in blood and buccal cells, tissues
from different germ layers. Recently, we described tissue
specificity of IGF2DMR and H19 gene regions among
four umbilical cord blood tissues and concluded that the
mononuclear cell fraction of umbilical cord blood is a
rather homogeneous cell population for methylation
studies (Herzog et al. 2013). However, no studies have
compared the agreement between umbilical cord blood
white blood cells and peripheral tissues as yet.
Second, folate and homocysteine concentrations were
determined in blood samples obtained in early preg-
nancy at the same time when information on maternal
folic acid supplement use was collected. A limitation ofwww.reproduction-online.org
Table 4 Associations between maternal periconceptional folic acid supplement use and newborn DNA methylation levels.
Methylation b (95% CI)
Unadjusted Adjusted
Start within 10 weeks No use Start within 10 weeks No use
Overall
All genes assessed 0.08 (K0.11; 0.27) K0.14 (K0.39; 0.11) 0.07 (K0.16; 0.31) 0.20 (K0.15; 0.54)
P value 0.42 0.27 0.56 0.26
Neurotransmitter systems
DRD4 0.35 (K0.64; 1.35) K5.56 (K1.87; 0.74) 0.94 (K0.06; 1.94) 0.67 (K0.72; 2.06)
P value 0.49 0.40 0.07 0.34
5-HTT_a K0.14 (K0.20; 0.37) K0.14 (K0.51; 0.23) 0.08 (K0.21; 0.38) K0.20 (K0.61; 0.21)
P value 0.55 0.46 0.57 0.33
5-HTT_b 0.10 (K0.22; 0.42) 0.28 (K0.16; 0.71) 0.16 (K0.16; 0.48) 0.47 (0.02; 0.92)
P value 0.54 0.21 0.32 0.04
5-HTT_c 0.07 (K0.27; 0.40) 0.15 (K0.29; 0.59) 0.09 (K0.24; 0.43) 0.17 (K0.30; 0.64)
P value 0.69 0.51 0.58 0.48
Metabolism
NR3C1_a 0.05 (K0.23; 0.12) K0.16 (K0.39; 0.07) 0.06 (K0.24; 0.12) K0.29 (K0.54;K0.03)
P value 0.56 0.17 0.52 0.03
NR3C1_b 0.20 (K0.04; 0.43) K0.07 (K0.37; 0.24) 0.18 (K0.06; 0.43) 0.01 (K0.33; 0.35)
P value 0.11 0.67 0.15 0.96
NR3C1_c 0.08 (K0.13; 0.29) K0.10 (K0.38; 0.18) 0.09 (K0.13; 0.31) K0.11 (K0.42; 0.20)
P value 0.46 0.47 0.43 0.48
MTHFR5 K0.01 (K0.18; 0.16) 0.13 (K0.09; 0.35) 0.02 (K0.16; 0.19) 0.13 (K0.11; 0.38)
P value 0.91 0.25 0.87 0.29
Fetal growth
H19 0.42 (K0.09; 0.93) K0.16 (K0.39; 0.07) 0.44 (K0.09; 0.97) 0.41 (K0.32; 1.14)
P value 0.10 0.39 0.10 0.27
IGF2DMR K0.03 (K0.73; 0.67) K0.87 (K1.79; 0.04) 0.23 (K0.49; 0.94) K0.41 (K1.40; 0.59)
P value 0.94 0.06 0.53 0.42
KCNQ1OT1 0.48 (K11.48; 1.08) 0.12 (K0.67; 0.91) 0.56 (K0.06; 1.19) 0.03 (K0.84; 0.90)
P value 0.11 0.76 0.08 0.95
A start preconceptionally was regarded as reference value. The b represents the change in methylation % in start within 10 weeks of pregnancy or no
use during pregnancy as analyzed with linear mixed models. Values represent b, 95% CIs, and P values. Analyses are adjusted for gestational age at
the moment of blood sampling, maternal educational level, smoking, child gender, birth weight, and gestational age at birth. The bold values
indicate statistical significance at the aZ0.05 level.
Pregnancy one-carbon metabolism and DNA methylation 587the study is the absence of information on the duration of
maternal folic acid use and repeated measurements of
these concentrations during gestation. Although it is not
known how DNA methylation of the fetus and placenta
develop throughout pregnancy, the epigenetic system is
thought to be primarily sensitive to environmental
factors during the period of developmental plasticity
(Barouki et al. 2012).
Third, in the current study we describe several
associations between determinants of maternal 1-C
metabolism and alterations in newborn DNA methyl-
ation profiles. However, it is difficult to describe the
potential influence of these effects on health outcomes. It
is difficult to translate our findings on newborn DNA
methylation to health outcomes, as literature describing
the effects of alterations in DNA methylation is limited.
Unfortunately, in the current study we were unable to
relate our findings to gene expression data. Therefore, it
would be valuable to replicate our findings and to
validate DNA methylationmarkers.
Fourth, for an initial overall analysis of determinants of
the maternal 1-C metabolism and newborn DNA
methylation, methylation levels of all CpG units in the
11 regions together were combined in one analysis. We
present the complete data from all regions selected andwww.reproduction-online.orgchose a hierarchical approach to reduce the risk of type 1
error rather than to report selectively. Next to specific
effects of DNA methylation, general effects on the level
of DNA methylation have been described. Besides, the
specific regions are correlated, a combined analysis
increases the power and helps to detect small effects of
DNA methylation. Consequently, we have to be very
careful to interpret specific effects on DNA methylation
as the focus was on the overall effect.
Finally, our study relied on genomic DNA extracted
from white blood cells, which consists of many distinct
populations in varying proportions. Therefore, cell
heterogeneity may act as a potential confounder
when investigating DNA methylation differences, if
cell distribution itself differs by one of investigated
determinants of the 1-C metabolism. Glossop et al.
(2013) demonstrated that DNA methylation
varied dramatically between matched-pairs T- and
B-lymphocytes in a population of healthy volunteers.
On the other hand, cellular heterogeneity is considered
to have limited impact when the outcome and the genes
are not involved in inflammation (Talens et al. 2010).
Reinius et al. (2012) evaluated genome wide DNA
methylation of w450 000 CpG sites in different periph-
eral blood mononuclear cells of six healthy adult maleReproduction (2014) 148 581–592
Table 5 Associations between the MTHFR C677T (rs1801133) genotype in mothers and newborns and newborn DNA methylation status.
Methylation b (95% CI)
Maternal genotype TT (nZ50) Child genotype TT (nZ50) Reference
Overall CC (nZ210)/CT (nZ203)
All genes assessed K0.31 (K0.59;K0.02) 0.01 (K0.20; 0.35)
P value 0.03 0.57
Neurotransmitter systems CC (nZ210)/CT (nZ203)
DRD4 K1.56 (K3.00;K0.08) K0.03 (K1.43; 1.37)
P value 0.04 0.97
5-HTT_a K0.22 (K0.65; 0.21) 0.03 (K0.44; 0.38)
P value 0.32 0.89
5-HTT_b 0.22 (K0.21; 0.66) 0.10 (0.37; 0.57)
P value 0.31 0.67
5-HTT_c 0.01 (K0.48; 0.50) K0.15 (0.63; 0.33)
P value 0.97 0.54
Metabolism CC (nZ210)/CT (nZ203)
NR3C1_a 0.10 (K0.16; 0.38) 0.25 (K0.02; 0.51)
P value 0.45 0.07
NR3C1_b 0.08 (K0.28; 0.44) K0.01 (K0.36; 0.34)
P value 0.67 0.97
NR3C1_c K0.16 (K0.48; 0.16) 0.06 (K0.24; 0.37)
P value 0.34 0.69
MTHFR5 0.12 (K0.15; 0.38) 0.15 (K0.45; 0.75)
P value 0.38 0.62
Fetal growth CC (nZ210)/CT (nZ203)
H19 K0.01 (K0.80; 0.78) K0.47 (K1.20; 0.26)
P value 0.98 0.21
IGF2DMR K0.55 (K1.62; 0.52) 0.50 (K0.53; 1.52)
P value 0.31 0.34
KCNQ1OT1 K0.89 (K1.80; 0.02) 0.04 (K0.81; 0.89)
P value 0.05 0.92
The b represents the change in methylation % in individuals with the MTHFR 677TT genotype compared with MTHFR 677CT or CC genotype as
analyzed with linear mixed models. Values represent b, 95% CIs, and P values. Analyses are adjusted for newborn birth weight. The bold values
indicate statistical significance at the aZ0.05 level.
588 N H van Mil and othersdonors. In selected genes implicated in immune-related
disorders, CpG methylation differed between mono-
nuclear cells and granulocytes and B-cells showing the
most distinct profile. Nevertheless, in future studies it
could be of added value when performing DNA
methylation analyses using whole blood, to adjust the
DNA methylation levels for differential cell counts or
preferably to evaluate cell-specific patterns for the locus
of interest.Interpretation
The association between maternal folate deficiency and
lower DNA methylation in newborns attenuated after
adjustment for maternal educational level, child gender,
birth weight, and gestational age at birth. It seems
likely that these determinants influence the newborn
epigenome also via the maternal 1-C metabolism
(Steegers-Theunissen et al. 2013). This is supported
by the observed gene-specific effects of gestational
age on newborn umbilical cord white blood cell
DNA and the reported relationship between maternal
smoking and lower methylation levels in the child
(Joubert et al. 2012).
Our data support the hypothesis that environmental
factors influence the epigenome, which can alter the
programing of gene expression and thus potentiallyReproduction (2014) 148 581–592contributes to health and disease in later life (Waterland
& Michels 2007). However, causality is difficult to
establish in observational studies and therefore con-
founding or presence of an epiphenomenon cannot be
excluded. Information on the factors which might
influence the fidelity of DNA methylation profiles is
limited. The association between maternal folate status
and DNA methylation in newborns could be subject to
confounding. This is illustrated by the attenuation of the
association after adjustment for confounders. On the
other hand, this is also a strength of our study, because in
most studies the control for socio-economic factors and
maternal smoking is lacking (Cortessis et al. 2012).
Folate is an important provider of methyl groups to 1-C
metabolism and hence a major determinant of SAM for
the establishment of the human epigenome. Human
studies of DNA methylation and folate concentration
vary widely in study design, timing and level of
exposure, tissue tested, and assays. Our data are
supported by the accumulating evidence on the
association between a low folate status and global
DNA hypomethylation (Crider et al. 2012). Studies of
the Dutch hunger winter showed alterations in offspring
DNA methylation patterns 60 years after intrauterine
exposure to famine, which might be an indicator
of a poor folate status (Heijmans et al. 2008, Tobi
et al. 2009). In addition, intervention studies inwww.reproduction-online.org
Pregnancy one-carbon metabolism and DNA methylation 589postmenopausal women have shown that moderate
folate deficiency reduces genome-wide DNA methyl-
ation (Jacob et al. 1998, Rampersaud et al. 2000).
Of interest is the finding that both folate deficiency
and higher homocysteine concentrations were associ-
ated with a decreased newborn DNA methylation level
of one of the glucocorticoid receptor gene loci. This
locus covers the noncoding exon 1F promoter that
contains the transcription factor NGFI-A-binding site
and is specific to the hippocampus (Turner & Muller
2005). It is suggested that glucocorticoid receptor
expression can be fine-tuned in response to the early
life environment. Previous studies investigating DNA
methylation in peripheral blood have shown increased
levels of NR3C1 methylation in response to neonatal
influences (Oberlander et al. 2008, Radtke et al. 2011,
Mulligan et al. 2012).
The results of studies addressing folic acid supplement
use are sometimes contradicting. We showed that
periconception maternal folic acid use significantly
increased IGF2DMR methylation in the very young
child (Steegers-Theunissen et al. 2009). In mice, low
folate supply in utero resulted in gene and locus-specific
epigenetic effects in the offspring gut. Lower overall
methylation was only in the Slc39a4 CGI1 locus and not
in Esr1, Igf2 DMR1, or Slc39a4 CGI2 loci (McKay et al.
2011). However, Haggarty et al. (2013) suggested that
preconception folic acid supplement use has no effect on
human child DNA methylation. Herein, we did not
observe any association between maternal folic acid
supplement use and DNA methylation of the combined
regions of seven genes in the newborn.
An approach that uses genetic variants as surrogate for
measuring exposure has the advantage to provide a
relatively unbiased assessment whether modifiable risk
factors are causally related to the outcome. Low folate
status increases the homocysteine concentration, in
particular in individuals with the MTHFR 677TT
genotype (Jacques et al. 1996). Consistent with the
epigenetic hypothesis, we observed an association
between the maternal MTHFR 677TT genotype and
lower DNA methylation level in newborns. This may
suggest that the maternal genotype is more reliable to
reflect the basic folate status than a single measurement
of the plasma folate concentration reflecting the folate
status of the previous 1–3 days. Unfortunately, we were
unable to test interactions or mediation effects due to the
small number of mothers and newborns carrying the
MTHFR 677CT/TT genotype and with folate deficiency.
In the current study, we observed that maternal MTHFR
677TT genotype is related with newborn DNA methyl-
ation, but newborn homozygosity for the C677T
mutation was not significantly associated with newborn
DNA methylation. From studies on associations between
folate and neural tube defects, we know that the odds
ratio was almost 1.5 times higher if not only the mother
but also the fetus carried the TT genotype (van der Putwww.reproduction-online.orget al. 1996), suggesting that the fetal genotype has an
additional effect on the maternal–fetal 1-C metabolism.
Other studies have previously reported the fetal ability to
concentrate vitamins. Active placental transport resulted
in higher levels of folate and vitamin B12 in the fetus than
in the mother (Obeid et al. 2005). Probably, because of
this mechanism, the fetus is able to maintain a sufficient
folate status regardless of its genotype. Furthermore, the
maternal 1-C metabolism is essential for DNA methyl-
ation reprograming during the early embryonic period
(Crider et al. 2012). Probably, this process of demethyl-
ation and remethylation takes place shortly after
fertilization, a long time before the fetal genotype
could exert its effect.
In the current study, we did not observe an association
between maternal folic acid supplement use and DNA
methylation in the newborn. Possibly the timing of the
start of folic acid supplement use could have influenced
our findings. DNA methylation reprograming in the early
embryo could benefit most from the use of supplements
if they are taken before conception (Steegers-Theunissen
et al. 2013). Another possibility is that the effects of folic
acid supplement use also depend on the MTHFR
genotype. Shelnutt et al. (2004) performed a trial in 41
young women with either the MTHFR 677CC or TT
genotype. A 7-week folate depletion diet led to lower
global DNA methylation in women with either geno-
type. However, the following 7-week folate repletion
diet only led to an increase in global DNA methylation in
women with the mutant TT genotype. It is possible that
natural folate as part of food exerts different effects on
biological processes than synthetic folic acid. It is not
elucidated whether the increased uptake of folic acid
rather than 5-methyltetrahydrofolate in the 1-C pathway
at a critical time can impact on DNA methylation (Smith
et al. 2008).
Experimental evidence is suggesting that epigenetic
marks serve as a memory of exposure in early life and
can increase the vulnerability to develop disease in later
life. In this study, changes in DNA methylation level in
response to the maternal the MTHFR genotype, although
statistically significant, were relatively small. The
magnitude of differences in DNA methylation is difficult
to interpret and most importantly the thresholds of
methylation to influence the expression of the gene are
largely unknown. The majority of studies of others only
examined a limited number of genetic regions and show
contradicting results (Crider et al. 2012). Results from the
current study reflect pooled data from DNA methylation
in different genomic regions. So far the biological basis
and implications of these altered profiles remain
unknown. Fetal growth and neuronal development are
characterized by widespread cell division. Inadequate
folate status led to several types of birth defects,
including certain heart defect, limb malformations, and
in particular neural tube defects. Pangilinan et al. (2012)
reported common genetic variants in 82 candidate genesReproduction (2014) 148 581–592
590 N H van Mil and othersselected from 1-C-pathway, including MTHFR, as risk
factors for neural tube defects. Other variants are involved
in, for example, choline metabolism, reabsorption of
vitamin B12, and mitochondrial folate transport. To date,
evidence from literature suggested that low folate status is
associated with decreases in global DNA methylation,
which has been associated with adverse health outcomes,
in particular cancer (Crider et al. 2012). However, as yet it
is unknown how specific genomic regions respond to
lower or higher folate intakes.Conclusion
This study suggests that the maternal MTHFR C677T
genotype is a determinant of the DNA methylation status
associated with some genes of the epigenome of the
newborn. Confounding factors including maternal
socio-demographic factors and pregnancy charac-
teristics, however, attenuated the association between
maternal folate deficiency and lower DNA methylation
in newborns. Therefore, further research to confirm our
results and to investigate the influence of the expression
of these genes and the implications for health is
recommended.Supplementary data
This is linked to the online version of the paper at http://dx.doi.
org/10.1530/REP-14-0260.Declaration of interest
The authors declare that there is no conflict of interest that
could be perceived as prejudicing the impartiality of the
research reported.Funding
The Generation R Study is made possible by financial support
from the Erasmus MC, University Medical Center Rotterdam;
Erasmus University Rotterdam; and The Netherlands Organiz-
ation for Health Research and Development (ZonMw)
‘Geestkracht’ programe (10.000.1003). N H van Mil was
supported by an additional grant from the Sophia Foundation
for Medical Research (SSWO grant number 268).Acknowledgements
The Generation R Study is conducted by the Erasmus MC,
University Medical Center Rotterdam in close collaboration
with the Faculty of Social Sciences of the Erasmus University
Rotterdam, the Municipal Health Service Rotterdam area,
the Rotterdam Homecare Foundation, and the Stichting
Trombosedienst & Artsenlaboratorium Rijnmond (STAR),
Rotterdam. The authors gratefully acknowledge the
contribution of all participants, general practitioners, hospitals,
midwives, and pharmacies in Rotterdam.Reproduction (2014) 148 581–592References
Barouki R, Gluckman PD, Grandjean P, Hanson M & Heindel JJ 2012
Developmental origins of non-communicable disease: implications for
research and public health. Environmental Health 11 42. (doi:10.1186/
1476-069X-11-42)
Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, Gilad Y &
Pritchard JK 2011 DNA methylation patterns associate with genetic and
gene expression variation in HapMap cell lines. Genome Biology 12
R10. (doi:10.1186/gb-2011-12-1-r10)
Bergen NE, Jaddoe VW, Timmermans S, Hofman A, Lindemans J,
Russcher H, Raat H, Steegers-Theunissen RP & Steegers EA 2012
Homocysteine and folate concentrations in early pregnancy and the risk
of adverse pregnancy outcomes: the Generation R Study. BJOG: an
International Journal of Obstetrics and Gynaecology 119 739–751.
(doi:10.1111/j.1471-0528.2012.03321.x)
Bouwland-Both MI, van Mil NH, Stolk L, Eilers PH, Verbiest MM,
Heijmans BT, Tiemeier H, Hofman A, Steegers EA, Jaddoe VW &
Steegers-Theunissen RP 2013 DNA methylation of IGF2DMR and H19 is
associated with fetal and infant growth: the generation R study. PLoS One
8 e81731. (doi: 10.1371/journal.pone.0081731)
Burton P, Gurrin L & Sly P 1998 Extending the simple linear regression
model to account for correlated responses: an introduction to
generalized estimating equations and multi-level mixed modelling.
Statistics in Medicine 17 1261–1291. (doi:10.1002/(SICI)1097-
0258(19980615)17:11!1261::AID-SIM846O3.0.CO;2-Z)
Cortessis VK, Thomas DC, Levine AJ, Breton CV, Mack TM, Siegmund KD,
Haile RW & Laird PW 2012 Environmental epigenetics: prospects for
studying epigenetic mediation of exposure–response relationships.
Human Genetics 131 1565–1589. (doi:10.1007/s00439-012-1189-8)
Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, Maneval DR,
Quinlivan EP, Li Z, Bailey LB et al. 2011 MTHFR 677C/T genotype is
associated with folate and homocysteine concentrations in a large,
population-based, double-blind trial of folic acid supplementation.
American Journal of Clinical Nutrition 93 1365–1372. (doi:10.3945/
ajcn.110.004671)
Crider KS, Yang TP, Berry RJ & Bailey LB 2012 Folate and DNA methylation:
a review of molecular mechanisms and the evidence for folate’s role.
Advances in Nutrition 3 21–38. (doi:10.3945/an.111.000992)
Fekete K, Berti C, Trovato M, Lohner S, Dullemeijer C, Souverein OW,
Cetin I & Decsi T 2012 Effect of folate intake on health outcomes in
pregnancy: a systematic review and meta-analysis on birth weight,
placental weight and length of gestation. Nutrition Journal 11 75.
(doi:10.1186/1475-2891-11-75)
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG,
Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al. 1995 A
candidate genetic risk factor for vascular disease: a common mutation in
methylenetetrahydrofolate reductase. Nature Genetics 10 111–113.
(doi:10.1038/ng0595-111)
Ghosh S, Yates AJ, Fruhwald MC, Miecznikowski JC, Plass C & Smiraglia D
2010 Tissue specific DNA methylation of CpG islands in normal human
adult somatic tissues distinguishes neural from non-neural tissues.
Epigenetics 5 527–538. (doi:10.4161/epi.5.6.12228)
Gilbody S, Lewis S & Lightfoot T 2007 Methylenetetrahydrofolate reductase
(MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE
review. American Journal of Epidemiology 165 1–13. (doi:10.1093/aje/
kwj347)
Glossop JR, Nixon NB, Emes RD, Haworth KE, Packham JC, Dawes PT,
Fryer AA, Mattey DL & Farrell WE 2013 Epigenome-wide profiling
identifies significant differences in DNA methylation between matched-
pairs of T- and B-lymphocytes from healthy individuals. Epigenetics 8
1188–1197. (doi:10.4161/epi.26265)
Gueant JL, Namour F, Gueant-Rodriguez RM & Daval JL 2013 Folate and
fetal programming: a play in epigenomics? Trends in Endocrinology and
Metabolism 24 279–289. (doi:10.1016/j.tem.2013.01.010)
Haggarty P, Hoad G, Campbell DM, Horgan GW, Piyathilake C &
McNeill G 2013 Folate in pregnancy and imprinted gene and repeat
element methylation in the offspring. American Journal of Clinical
Nutrition 97 94–99. (doi:10.3945/ajcn.112.042572)
Hague WM 2003 Homocysteine and pregnancy. Best Practice & Research.
Clinical Obstetrics & Gynaecology 17 459–469. (doi:10.1016/S1521-
6934(03)00009-9)www.reproduction-online.org
Pregnancy one-carbon metabolism and DNA methylation 591Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES,
Slagboom PE & Lumey LH 2008 Persistent epigenetic differences
associated with prenatal exposure to famine in humans. PNAS 105
17046–17049. (doi:10.1073/pnas.0806560105)
Herzog E, Galvez J, Roks A, Stolk L, Verbiest M, Eilers P, Cornelissen J,
Steegers E & Steegers-Theunissen R 2013 Tissue-specific DNA
methylation profiles in newborns. Clinical Epigenetics 5 8. (doi:10.
1186/1868-7083-5-8)
Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ,
Henning SM & Swendseid ME 1998 Moderate folate depletion increases
plasma homocysteine and decreases lymphocyte DNA methylation in
postmenopausal women. Journal of Nutrition 128 1204–1212.
Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH,
Rosenberg IH, Selhub J & Rozen R 1996 Relation between folate status,
a common mutation in methylenetetrahydrofolate reductase, and plasma
homocysteine concentrations. Circulation 93 7–9. (doi:10.1161/01.CIR.
93.1.7)
Jacques PF, Kalmbach R, Bagley PJ, Russo GT, Rogers G, Wilson PW,
Rosenberg IH & Selhub J 2002 The relationship between riboflavin and
plasma total homocysteine in the Framingham Offspring cohort is
influenced by folate status and the C677T transition in the methylenete-
trahydrofolate reductase gene. Journal of Nutrition 132 283–288.
Jaddoe VW, van Duijn CM, Franco OH, van der Heijden AJ, van
Iizendoorn MH, de Jongste JC, van der Lugt A, Mackenbach JP,
Moll HA, Raat H et al. 2012 The Generation R Study: design and cohort
update 2012. European Journal of Epidemiology 27 739–756. (doi:10.
1007/s10654-012-9735-1)
Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK,
Huang Z, Hoyo C, Midttun O, Cupul-Uicab LA et al. 2012 450K
epigenome-wide scan identifies differential DNA methylation in new-
borns related to maternal smoking during pregnancy. Environmental
Health Perspectives 120 1425–1431. (doi:10.1289/ehp.1205412)
Kim MW, Hong SC, Choi JS, Han JY, Oh MJ, Kim HJ, Nava-Ocampo A &
Koren G 2012 Homocysteine, folate and pregnancy outcomes. Journal of
Obstetrics and Gynaecology 32 520–524. (doi:10.3109/01443615.
2012.693984)
McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonte B, Szyf M,
Turecki G &MeaneyMJ 2009 Epigenetic regulation of the glucocorticoid
receptor in human brain associates with childhood abuse. Nature
Neuroscience 12 342–348. (doi:10.1038/nn.2270)
McKay JA, Wong YK, Relton CL, Ford D &Mathers JC 2011 Maternal folate
supply and sex influence gene-specific DNA methylation in the fetal gut.
Molecular Nutrition & Food Research 55 1717–1723. (doi:10.1002/mnfr.
201100150)
McKay JA, Groom A, Potter C, Coneyworth LJ, Ford D, Mathers JC &
Relton CL 2012 Genetic and non-genetic influences during pregnancy
on infant global and site specific DNA methylation: role for folate gene
variants and vitamin B12. PLoS ONE 7 e33290. (doi:10.1371/journal.
pone.0033290)
MulliganCJ,D’ErricoNC, Stees J&HughesDA2012 Methylation changes at
NR3C1 in newborns associate with maternal prenatal stress exposure and
newborn birth weight. Epigenetics 7 853–857. (doi:10.4161/epi.21180)
Niculescu MD & Zeisel SH 2002 Diet, methyl donors and DNA
methylation: interactions between dietary folate, methionine and
choline. Journal of Nutrition 132 2333S–2335S.
Obeid R, Munz W, Jager M, Schmidt W & Herrmann W 2005 Biochemical
indexes of the B vitamins in cord serum are predicted by maternal B
vitamin status. American Journal of Clinical Nutrition 82 133–139.
Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S & Devlin AM
2008 Prenatal exposure to maternal depression, neonatal methylation of
human glucocorticoid receptor gene (NR3C1) and infant cortisol stress
responses. Epigenetics 3 97–106. (doi:10.4161/epi.3.2.6034)
Obermann-Borst SA, van Driel LM, Helbing WA, de Jonge R,
Wildhagen MF, Steegers EA & Steegers-Theunissen RP 2011 Congenital
heart defects and biomarkers of methylation in children: a case–control
study. European Journal of Clinical Investigation 41 143–150. (doi:10.
1111/j.1365-2362.2010.02388.x)
Pangilinan F, Molloy AM, Mills JL, Troendle JF, Parle-McDermott A,
Signore C, O’Leary VB, Chines P, Seay JM, Geiler-Samerotte K et al.
2012 Evaluation of common genetic variants in 82 candidate genes as
risk factors for neural tube defects. BMC Medical Genetics 13 62.
(doi:10.1186/1471-2350-13-62)www.reproduction-online.orgPhilibert RA, Sandhu H, Hollenbeck N, Gunter T, Adams W & Madan A
2008 The relationship of 5HTT (SLC6A4) methylation and genotype on
mRNA expression and liability to major depression and alcohol
dependence in subjects from the Iowa Adoption Studies. American
Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B
543–549. (doi:10.1002/ajmg.b.30657)
van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJ,
Eskes TK, Mariman EC, den Heyer M & Blom HJ 1996 Decreased
methylene tetrahydrofolate reductase activity due to the 677C/T
mutation in families with spina bifida offspring. Journal of Molecular
Medicine 74 691–694. (doi:10.1007/s001090050073)
van Mil N, Steegers-Theunissen RP, Bouwland-Both MI, Verbiest MM,
Rijlaarsdam J, Hofman A, Steegers EA, Heijmans BT, Jaddoe VW,
Verhulst FC, Stolk L, Eilers PH, Uitterlinden AG & Tiemeier H 2014
DNA methylation profiles at birth and child ADHD symptoms. Journal of
Psychiatric Research 49 51–59. (doi:10.1016/j.jpsychires.2013.10.017)
Radtke KM, Ruf M, Gunter HM, Dohrmann K, Schauer M, Meyer A &
Elbert T 2011 Transgenerational impact of intimate partner violence on
methylation in the promoter of the glucocorticoid receptor. Translational
Psychiatry 1 e21. (doi:10.1038/tp.2011.21)
Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ & Bailey LB 2000
Genomic DNA methylation decreases in response to moderate folate
depletion in elderly women. American Journal of Clinical Nutrition 72
998–1003.
Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlen SE, Greco D,
Soderhall C, Scheynius A & Kere J 2012 Differential DNA methylation in
purified human blood cells: implications for cell lineage and studies on
disease susceptibility. PLoS ONE 7 e41361. (doi:10.1371/journal.pone.
0041361)
Roza SJ, van Batenburg-Eddes T, Steegers EA, Jaddoe VW, Mackenbach JP,
Hofman A, Verhulst FC & Tiemeier H 2010 Maternal folic acid
supplement use in early pregnancy and child behavioural problems:
the Generation R Study. British Journal of Nutrition 103 445–452.
(doi:10.1017/S0007114509991954)
Shames DS, Minna JD & Gazdar AF 2007 DNA methylation in health,
disease, and cancer. Current Molecular Medicine 7 85–102. (doi:10.
2174/156652407779940413)
Shelnutt KP, Kauwell GP, Gregory JF III, Maneval DR, Quinlivan EP,
Theriaque DW, Henderson GN & Bailey LB 2004 Methylenetetra-
hydrofolate reductase 677C/T polymorphism affects DNA methylation
in response to controlled folate intake in young women. Journal of
NutritionalBiochemistry15554–560. (doi:10.1016/j.jnutbio.2004.04.003)
Simpson JL, Bailey LB, Pietrzik K, Shane B & Holzgreve W 2010
Micronutrients and women of reproductive potential: required dietary
intake and consequences of dietary deficiency or excess. Part I – folate,
vitamin B12, vitamin B6. Journal of Maternal–Fetal & Neonatal Medicine
23 1323–1343. (doi:10.3109/14767051003678234)
Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J,
Thurston A, Huntley JF, Rees WD, Maloney CA et al. 2007 DNA
methylation, insulin resistance, and blood pressure in offspring
determined by maternal periconceptional B vitamin and methionine
status. PNAS 104 19351–19356. (doi:10.1073/pnas.0707258104)
Smith AD, Kim YI & Refsum H 2008 Is folic acid good for everyone?
American Journal of Clinical Nutrition 87 517–533.
Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J,
Siebel C, Steegers EA, Slagboom PE & Heijmans BT 2009 Periconcep-
tional maternal folic acid use of 400 microg per day is related to
increased methylation of the IGF2 gene in the very young child. PLoS
ONE 4 e7845. (doi:10.1371/journal.pone.0007845)
Steegers-Theunissen RP, Twigt J, Pestinger V & Sinclair KD 2013 The
periconceptional period, reproduction and long-term health of offspring:
the importance of one-carbon metabolism. Human Reproduction
Update 19 640–655. (doi:10.1093/humupd/dmt041)
Talens RP, Boomsma DI, Tobi EW, Kremer D, Jukema JW, Willemsen G,
Putter H, Slagboom PE & Heijmans BT 2010 Variation, patterns, and
temporal stability of DNA methylation: considerations for epigenetic
epidemiology. FASEB Journal 24 3135–3144. (doi:10.1096/fj.09-
150490)
Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE
& Heijmans BT 2009 DNA methylation differences after exposure to
prenatal famine are common and timing- and sex-specific. Human
Molecular Genetics 18 4046–4053. (doi:10.1093/hmg/ddp353)Reproduction (2014) 148 581–592
592 N H van Mil and othersTurner JD & Muller CP 2005 Structure of the glucocorticoid receptor
(NR3C1) gene 5 0 untranslated region: identification, and tissue
distribution of multiple new human exon 1. Journal of Molecular
Endocrinology 35 283–292. (doi:10.1677/jme.1.01822)
van Uitert EM, van der Elst-Otte N, Wilbers JJ, Exalto N, Willemsen SP,
Eilers PH, Koning AH, Steegers EA & Steegers-Theunissen RP 2013
Periconception maternal characteristics and embryonic growth tra-
jectories: the Rotterdam Predict study. Human Reproduction 28
3188–3196. (doi:10.1093/humrep/det375)
Verburg BO, Steegers EA, De Ridder M, Snijders RJ, Smith E, Hofman A,
Moll HA, Jaddoe VW & Witteman JC 2008 New charts for ultrasound
dating of pregnancy and assessment of fetal growth: longitudinal data
from a population-based cohort study. Ultrasound in Obstetrics &
Gynecology 31 388–396. (doi:10.1002/uog.5225)
Walter S & Tiemeier H 2009 Variable selection: current practice in
epidemiological studies. European Journal of Epidemiology 24 733–736.
(doi:10.1007/s10654-009-9411-2)
Waterland RA & Jirtle RL 2004 Early nutrition, epigenetic changes at
transposons and imprinted genes, and enhanced susceptibility to adult
chronic diseases. Nutrition 20 63–68. (doi:10.1016/j.nut.2003.09.011)
Waterland RA & Michels KB 2007 Epigenetic epidemiology of the
developmental origins hypothesis. Annual Review of Nutrition 27
363–388. (doi:10.1146/annurev.nutr.27.061406.093705)Reproduction (2014) 148 581–592Waterland RA, Dolinoy DC, Lin JR, Smith CA, Shi X & Tahiliani KG 2006
Maternal methyl supplements increase offspring DNA methylation at
Axin Fused. Genesis 44 401–406. (doi:10.1002/dvg.20230)
Weggemans RM, Schaafsma G, Kromhout D & Health Council of The
Netherlands 2009 Toward an optimal use of folic acid: an advisory
report of the Health Council of The Netherlands. European Journal of
Clinical Nutrition 63 1034–1036. (doi:10.1038/ejcn.2009.2)
Wong CC, Caspi A, Williams B, Craig IW, Houts R, Ambler A, Moffitt TE &
Mill J 2010 A longitudinal study of epigenetic variation in twins.
Epigenetics 5 516–526. (doi:10.4161/epi.5.6.12226)
Zhang D, Cheng L, Badner JA, Chen C, Chen Q, Luo W, Craig DW,
Redman M, Gershon ES & Liu C 2010 Genetic control of
individual differences in gene-specific methylation in human
brain. American Journal of Human Genetics 86 411–419. (doi:10.
1016/j.ajhg.2010.02.005)
Received 20 May 2014
First decision 11 June 2014
Revised manuscript received 6 August 2014
Accepted 18 September 2014www.reproduction-online.org
